98 related articles for article (PubMed ID: 17446718)
1. Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.
Dalle Carbonare L; Valenti MT; Bertoldo F; Fracalossi A; Balducci E; Azzarello G; Vinante O; Lo Cascio V
Aging Clin Exp Res; 2007 Apr; 19(2):91-6. PubMed ID: 17446718
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S
Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718
[TBL] [Abstract][Full Text] [Related]
3. The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells.
Valenti MT; Dalle Carbonare L; Bertoldo F; Donatelli L; Lo Cascio V
Eur J Pharmacol; 2008 Feb; 580(1-2):36-42. PubMed ID: 18037402
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates induce breast cancer cell death in vitro.
Fromigue O; Lagneaux L; Body JJ
J Bone Miner Res; 2000 Nov; 15(11):2211-21. PubMed ID: 11092402
[TBL] [Abstract][Full Text] [Related]
5. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
Vorotnjak M; Boos J; Lanvers-Kaminsky C
Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642
[TBL] [Abstract][Full Text] [Related]
6. Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) alpha+beta+ transcript in estrogen receptor-positive MCF-7 breast cancer cells.
Strati A; Papoutsi Z; Lianidou E; Moutsatsou P
Clin Biochem; 2009 Sep; 42(13-14):1358-62. PubMed ID: 19501078
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates induce apoptosis in human breast cancer cell lines.
Senaratne SG; Pirianov G; Mansi JL; Arnett TR; Colston KW
Br J Cancer; 2000 Apr; 82(8):1459-68. PubMed ID: 10780527
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of bisphosphonates on breast cancer cell lines.
Verdijk R; Franke HR; Wolbers F; Vermes I
Cancer Lett; 2007 Feb; 246(1-2):308-12. PubMed ID: 16621245
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
Rao Y; Xiong W; Liu H; Jia C; Zhang H; Cui Z; Zhang Y; Cui J
Breast Cancer; 2016 Mar; 23(2):216-23. PubMed ID: 25098685
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: preclinical aspects and use in osteoporosis.
Fleisch HA
Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
[TBL] [Abstract][Full Text] [Related]
12. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
Daniel M; Tollefsbol TO
J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889
[TBL] [Abstract][Full Text] [Related]
13. Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells.
Nasiri M; Zarghami N; Koshki KN; Mollazadeh M; Moghaddam MP; Yamchi MR; Esfahlan RJ; Barkhordari A; Alibakhshi A
Asian Pac J Cancer Prev; 2013; 14(6):3449-53. PubMed ID: 23886126
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
[TBL] [Abstract][Full Text] [Related]
15. The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium.
Twiss IM; Pas O; Ramp-Koopmanschap W; Den Hartigh J; Vermeij P
J Bone Miner Res; 1999 May; 14(5):784-91. PubMed ID: 10320527
[TBL] [Abstract][Full Text] [Related]
16. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
Frith JC; Rogers MJ
J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
[TBL] [Abstract][Full Text] [Related]
17. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
Knight LA; Conroy M; Fernando A; Polak M; Kurbacher CM; Cree IA
Anticancer Drugs; 2005 Oct; 16(9):969-76. PubMed ID: 16162973
[TBL] [Abstract][Full Text] [Related]
18. Analgesic effect of bisphosphonates in mice.
Bonabello A; Galmozzi MR; Bruzzese T; Zara GP
Pain; 2001 Apr; 91(3):269-275. PubMed ID: 11275384
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids.
Choi SH; Kang HK; Im EO; Kim YJ; Bae YT; Choi YH; Lee KH; Chung HY; Chang HK; Kim ND
Int J Oncol; 2000 Nov; 17(5):971-6. PubMed ID: 11029500
[TBL] [Abstract][Full Text] [Related]
20. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
